These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2109484)

  • 21. Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I. The Mother-to-Child Transmission Study Group.
    Takahashi K; Takezaki T; Oki T; Kawakami K; Yashiki S; Fujiyoshi T; Usuku K; Mueller N; Osame M; Miyata K
    Int J Cancer; 1991 Nov; 49(5):673-7. PubMed ID: 1937953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating the time of HTLV-I infection following mother-to-child transmission in a breast-feeding population in Jamaica.
    Furnia A; Lal R; Maloney E; Wiktor S; Pate E; Rudolph D; Waters D; Blattner W; Manns A
    J Med Virol; 1999 Dec; 59(4):541-6. PubMed ID: 10534739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human T lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mapping.
    Zhang XQ; Yang L; Ho DD; Kuritzkes DR; Chen IS; Ching WT; Chen YM; Schooley RT
    J Infect Dis; 1992 May; 165(5):805-12. PubMed ID: 1373751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.
    Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kärre K; Kent SJ; Berg L
    Viral Immunol; 2011 Oct; 24(5):359-68. PubMed ID: 21958370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of HTLV-I genome in infants born to HTLV-I seropositive mothers by polymerase chain reaction].
    Saito S; Ando Y; Furuki K; Tanigawa T; Kakimoto K; Moriyama I; Ichijo M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):234-40. PubMed ID: 2332671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody-dependent cell-mediated cytotoxicity: comparison between HTLV-I and HIV-1 assays.
    Sinclair AL; Habeshaw JA; Muir L; Chandler P; Forster S; Cruickshank K; Dalgleish AG
    AIDS; 1988 Dec; 2(6):465-72. PubMed ID: 3149493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vertical transmission human T-cell lymphotropic virus type-I (HTLV-I)--genetic diagnosis and assessment of the probable routes of HTLV-I infection].
    Ikeda K; Inaba N; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1283-8. PubMed ID: 7903107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of human T-lymphotropic virus type-1 (HTLV-1)-infected cell line MT-2, which is not killed by a natural killer cell line NK-92 but is killed by lymphokine-activated killer cells.
    Komatsu F; Yoshida S
    Oncol Res; 1999; 11(5):213-8. PubMed ID: 10608615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired antibody-dependent cellular cytotoxicity mediated by herceptin in patients with gastric cancer.
    Kono K; Takahashi A; Ichihara F; Sugai H; Fujii H; Matsumoto Y
    Cancer Res; 2002 Oct; 62(20):5813-7. PubMed ID: 12384543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human leukocyte antigen concordance and the transmission risk via breast-feeding of human T cell lymphotropic virus type I.
    Biggar RJ; Ng J; Kim N; Hisada M; Li HC; Cranston B; Hanchard B; Maloney EM
    J Infect Dis; 2006 Jan; 193(2):277-82. PubMed ID: 16362892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of route of delivery on neonatal natural killer cytotoxicity and antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells.
    Frazier JP; Kohl S; Pickering LK; Loo LS
    Pediatr Res; 1982 Jul; 16(7):558-60. PubMed ID: 6287398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection of human natural killer (NK) cells with replication-defective human T cell leukemia virus type I provirus. Increased proliferative capacity and prolonged survival of functionally competent NK cells.
    Lo KM; Vivier E; Rochet N; Dehni G; Levine H; Haseltine WA; Anderson P
    J Immunol; 1992 Dec; 149(12):4101-8. PubMed ID: 1460293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A decrease in mother-to-child transmission of human T lymphotropic virus type I (HTLV-I) in Okinawa, Japan.
    Kashiwagi K; Furusyo N; Nakashima H; Kubo N; Kinukawa N; Kashiwagi S; Hayashi J
    Am J Trop Med Hyg; 2004 Feb; 70(2):158-63. PubMed ID: 14993627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies against p40tax gene product of human T-lymphotropic virus type-I (HTLV-I) under various conditions of HTLV-I infection.
    Kamihira S; Toriya K; Amagasaki T; Momita S; Ikeda S; Yamada Y; Tomonaga M; Ichimaru M; Kinoshita K; Sawada T
    Jpn J Cancer Res; 1989 Nov; 80(11):1066-71. PubMed ID: 2514169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products.
    Itescu S; Artrip JH; Kwiatkowski PA; Wang SF; Minanov OP; Morgenthau AS; Michler RE
    Ann Transplant; 1997; 2(1):14-20. PubMed ID: 9869836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mother-to-child transmission of human T-lymphotropic virus type II.
    Van Dyke RB; Heneine W; Perrin ME; Rudolph D; Starszak E; Woods T; Switzer WM; Kaplan JE
    J Pediatr; 1995 Dec; 127(6):924-8. PubMed ID: 8523190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement-dependent cytotoxic antibodies to human T lymphotropic virus type I (HTLV-I)-infected cells in the sera of HTLV-I-infected individuals.
    Plotnicky-Gilquin H; Afani A; Vernant JC; Desgranges C
    Clin Exp Immunol; 1996 Jul; 105(1):39-45. PubMed ID: 8697633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.